Gene · 113451
Papers1,387
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,387
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From intracellular processing to renal phenotypes: a mechanism-informed framework for interpreting kidney injury and electrolyte patterns with antibody-drug conjugates in solid tumors. | Front Pharmacol | 2026 | 42434135 | PubTator, text mining | PubMed |
| A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patients. | J Liq Biopsy | 2026 | 42433605 | PubTator, text mining | PubMed |
| Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology. | Acta Cytol | 2026 | 42406652 | PubTator, text mining | PubMed |
| Novel ADC and γδ T cell engager targeting CDH17 for the therapy of gastrointestinal cancers. | Antib Ther | 2026 | 42382978 | PubTator, text mining | PubMed |
| [Consensus of Chinese experts on the multidisciplinary management of adverse reactions to antibody-drug conjugates in the treatment of lung cancer (2025 edition)]. | Zhonghua Zhong Liu Za Zhi | 2026 | 42331546 | PubTator, text mining | PubMed |
| NAV-005, a high-affinity MUC16/CA125 antagonist for the treatment of humoral immunosuppressed cancers. | BMC Cancer | 2026 | 42321642 | PubTator, text mining | PubMed |
| Coil-Tag Conjugation: A Next Gen Site-Specific ADC Fabrication Technology. | Bioconjugate Insights | 2026 | 42306122 | PubTator, text mining | PubMed |
| 7MeERT Enhances Antibody-Drug Conjugate Efficacy in Glioblastoma by Inducing AMPK-p38MAPK-Mediated Non-Canonical Endocytosis of EGFRvIII. | Anticancer Agents Med Chem | 2026 | 42300319 | PubTator, text mining | PubMed |
| A Tumor-Responsive Enzymatic Cascade System Inducing pH-Activable Metabolic Starvation and H2O2-Induced Apoptosis. | Biomater Res | 2026 | 42272935 | PubTator, text mining | PubMed |
| Cutaneous adverse events with antibody-drug conjugates: a FAERS-based pharmacovigilance study. | Front Med (Lausanne) | 2026 | 42266949 | PubTator, text mining | PubMed |
| A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia. | Leukemia | 2026 | 42260111 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects. | Front Immunol | 2026 | 42254025 | PubTator, text mining | PubMed |
| Histology-specific ADC target landscapes in ovarian cancer and therapy-associated antigen downshift after ADC exposure. | Gynecol Oncol | 2026 | 42235136 | PubTator, text mining | PubMed |
| Artificial Intelligence-Driven Quantitative HER2 Scoring and Spatial Bystander Effect Modeling for ADC Response Stratification in HER2-Low Breast Cancer. | Breast Cancer (Dove Med Press) | 2026 | 42232721 | PubTator, text mining | PubMed |
| Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma. | Br J Cancer | 2026 | 42231029 | PubTator, text mining | PubMed |
| When more target antigen expression is less. | Cancer Cell | 2026 | 42208541 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for primary brain tumors. | Front Oncol | 2026 | 42180101 | PubTator, text mining | PubMed |
| Narrative review of the similarities and differences between immune checkpoint inhibitor- and antibody-drug conjugate-associated pneumonitis. | Transl Lung Cancer Res | 2026 | 42170261 | PubTator, text mining | PubMed |
| Anchor-Driven Compact Gaussian Splatting for Dynamic Scene Reconstruction. | IEEE Trans Vis Comput Graph | 2026 | 42160255 | PubTator, text mining | PubMed |
Development of a generic physiologically based pharmacokinetic model to predict clinical pharmacokinetics and assess drug-drug interaction risks for valine-citrulline-monomethyl auristatin E-based antibody-drug conjugates. | Drug Metab Dispos | 2026 | 42066734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/113451/papers?page=2